![Christopher Leamon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Leamon
Technik-/Wissenschafts-/F&E-Leiter bei
FUSN PHAR
Profil
Christopher P.
Leamon is Chief Scientific Officer at Fusion Pharmaceuticals, Inc. since 2021.
Formerly, Dr. Leamon was Executive Director-Radioligand Drug Discovery at Novartis Institutes for Biomedical Research, Inc., Principal at Glaxo Wellcome Plc, Vice President-Research at Endocyte, Inc. from 1999 to 2011, and Vice President-Discovery Research at Advanced Accelerator Applications USA, Inc. Education includes undergraduate studies at Baldwin-Wallace College and a doctorate from Purdue University.
Aktive Positionen von Christopher Leamon
| Unternehmen | Position | Beginn |
|---|---|---|
| FUSN PHAR | Technik-/Wissenschafts-/F&E-Leiter | 02.11.2021 |
Ehemalige bekannte Positionen von Christopher Leamon
| Unternehmen | Position | Ende |
|---|---|---|
Advanced Accelerator Applications USA, Inc.
 Advanced Accelerator Applications USA, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes MNM diagnostic and therapeutic products | Corporate Officer/Principal | - |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
| ENDOCYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Christopher Leamon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Glaxo Wellcome Plc
Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Baldwin-Wallace College
 Baldwin-Wallace College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Advanced Accelerator Applications USA, Inc.
Advanced Accelerator Applications USA, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes MNM diagnostic and therapeutic products | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
